-
公开(公告)号:CA3113377A1
公开(公告)日:2020-04-16
申请号:CA3113377
申请日:2018-10-11
Applicant: SANIFIT THERAPEUTICS S A
IPC: A61K31/6615 , A61K9/00 , A61K31/661 , A61K45/06 , A61P17/02 , A61P43/00
Abstract: The present disclosure related to compositions, methods, dosages, dosage regimens, articles of manufacture and kits for the treatment and/or prevention ectopic calcifications, and in particular cutaneous calcifications such as calciphylaxis calcifications comprising inositol phosphate, inositol phosphate analogs, inositol phosphate derivatives, or combinations thereof. In a particular aspect the disclosure provides a dosage regimen to treat calciphylaxis comprising the administration of 6 mg/kg to 9 mg/kg daily doses of myo-inositol hexaphosphate, three times a week, for at least 1 to 8 months.